Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual Meeting 2024-05-24 22:00
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024 2024-05-24 20:00
K-Pet develops disease prevention solutions to extend the healthy life of pets 2024-05-24 18:13
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor 2024-05-24 16:33
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-05-24 16:32
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology Company 2024-05-24 13:00
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates 2024-05-24 09:15
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 2024-05-24 08:00
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024 2024-05-23 23:00
Computex 2024: DeCloak Intelligences Showcases DeCloakVision Multi-Modal AI Privacy-Enhanced Monitoring System Offering the Optimal Balance between Public Safety & Personal Privacy 2024-05-23 22:00
Vatech Partners with Tygerberg Public Hospital to Improve Dental Care in South Africa 2024-05-23 21:00
Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 2024-05-23 21:00
Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer 2024-05-23 20:42
111, Inc. Announces First Quarter 2024 Unaudited Financial Results 2024-05-23 16:43
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 2024-05-23 08:51
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies 2024-05-23 07:23
Aiming for New Quality Productivity, Aiding in Reaching the Summit of Global Innovative Pharmaceuticals 2024-05-22 22:38
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care 2024-05-22 21:00
GV Announces Cooperation with CICC 2024-05-22 20:30
I-Mab to Participate at the Jefferies Global Healthcare Conference 2024-05-22 19:00
1 43 44 45 46 47 812